Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.
|Articles|April 26, 2023
Get eTOC alerts from Urogynecology
Author(s)American Urogynecologic Society
Advertisement
Never miss an issue! Get new journal Tables of Contents sent right to your email by following these steps:
- Scroll down to the bottom and enter your email above “Get New Issue Alerts” or click “Get eTOC Alerts” to subscribe.
Advertisement
Related to this article
These FAQs outline key recommendations and practical takeaways from the AUA/SUFU/AUGS Genitourinary Syndrome of Menopause guideline.
Advertisement
Advertisement
Trending on Urology Times
1
Novel RIPTAC molecule shows promising activity in heavily pretreated mCRPC
2
Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC
3
LUGPA 2026: Midterms, AI, and ancillary services take center stage
4
CLARIFY trial reaches enrollment target for 64Cu-SAR-bisPSMA in prostate cancer
5